Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Nitric Oxide ; 71: 21-26, 2017 Dec 01.
Article in English | MEDLINE | ID: mdl-29031734

ABSTRACT

Shear stress or vasocontriction causes endothelial nitric oxide (NO) release resulting in the regulation of vascular smooth muscle tone in small resistance arteries. Generation of NO is inhibited by nitric oxide synthase (NOS) inhibitors. In this study, we investigated the effect of residual NO, released even in the presence of NOS inhibitors, on the membrane depolarization and phenylephrine-induced contractions of smooth muscle. For this purpose, we used hydroxocobalamin (HC), an NO scavenger, in the presence of NOS inhibitiors, Nω-nitro- L-arginine (L-NA) or Nω-nitro-L-arginine methyl ester (L-NAME) in mesenteric arteries isolated from rats. Phenylephrine (0,01-10 µM), an α1-adrenoceptor agonist, led to depolarisation and concentration-dependent contraction in mesenteric arteries. The depolarisation and contractile responses were augmented by L-NA or L-NAME. Hydroxocobalamine (HC) or carboxy-PTIO (c-PTIO) also caused to further increase the membrane depolarization and contractions induced by phenylephrine in the presence of NOS inhibitors. Chemical removal of endothelium by saponin, tyrosin kinase inhibitor erbstatin A, but not calmodulin inhibitor calmidazolium inhibited the additional membrane depolarisation and contractile responses induced by L-NA or L-NAME and L-NA or L-NAME plus HC. These findings show that residual NO modulates the contractile responses in isolated rat mesenteric arteries by exerting a tonic inhibitor effect on the depolarization and vasoconstriction induced by phenylephrine.


Subject(s)
Membrane Potentials/drug effects , Mesenteric Arteries/metabolism , Muscle Contraction/drug effects , Nitric Oxide/metabolism , Adrenergic alpha-1 Receptor Agonists/pharmacology , Animals , Benzoates/pharmacology , Free Radical Scavengers/pharmacology , Hydroxocobalamin/pharmacology , Imidazoles/pharmacology , Male , Mesenteric Arteries/drug effects , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Nitroarginine/pharmacology , Phenylephrine/pharmacology , Protein Kinase Inhibitors/pharmacology , Rats, Wistar
2.
J Basic Clin Physiol Pharmacol ; 24(2): 143-50, 2013.
Article in English | MEDLINE | ID: mdl-23412870

ABSTRACT

BACKGROUND: The aim of this study was to investigate whether thiols are involved in the nitrergic neurotransmission in mouse duodenum. METHODS: The effects of thiol-modulating agents, ethacrynic acid (100 µM), a non-specific sulfhydryl alkylator, and diamide (100 µM), an alkylating agent that oxidizes protein sulfhydryl groups and depletes intracellular glutathione, on relaxations to nitrergic stimulation (electrical field stimulation, EFS;10 Hz, 25 V, 1 ms, 15 s-train), S-nitrosoglutathione (GSNO; 5 µM), S-nitroso-acetylpenicillamine (SNAP; 5 µM), and S-nitrosocysteine (CysNO; 10 µM) were investigated. Moreover, the effects of buthionine sulfoximine (100 µM), an inhibitor of γ-glutamylcysteine synthetase, and sulfobromophthalein (100 µM), an inhibitor of glutathione-S-transferase, were studied on relaxant responses to EFS and S-nitrosothiols in mouse duodenum. RESULTS: Exogenous free thiol, glutathione (GSH, 100 µM) did not influence relaxation to EFS, GSNO, SNAP, and CysNO. Ethacrynic acid and diamide significantly decreased relaxation of duodenum to EFS, GSNO, SNAP, and CysNO. This inhibition was prevented by addition of GSH. Buthionine sulfoximine and sulfobromophthalein significantly decreased relaxation to EFS and GSNO but did not influence relaxation to SNAP and CysNO. The inhibitory effect of buthionine sulfoximine and sulfobromophthalein on the relaxant response to EFS and GSNO was prevented by addition of GSH. CONCLUSIONS: These results suggest that relaxation to nitrergic stimulation is thiol-dependent, and nitrosothiols, possibly S-nitrosoglutathione may play a role, as an intermediate compound in nitrergic neurotransmission in mouse duodenum.


Subject(s)
Duodenum/drug effects , Muscle Relaxation/drug effects , Nitric Oxide Donors/pharmacology , Nitric Oxide/physiology , S-Nitrosothiols/pharmacology , Sulfhydryl Reagents/pharmacology , Analysis of Variance , Animals , Buthionine Sulfoximine/pharmacology , Cysteine/analogs & derivatives , Cysteine/pharmacology , Diuretics/pharmacology , Dose-Response Relationship, Drug , Ethacrynic Acid/pharmacology , Female , Glutamate-Cysteine Ligase/antagonists & inhibitors , Glutathione Transferase/antagonists & inhibitors , Male , Mice , S-Nitroso-N-Acetylpenicillamine/pharmacology , S-Nitrosoglutathione/pharmacology , Sulfobromophthalein/pharmacology , Synaptic Transmission/drug effects , Vasodilator Agents/pharmacology
3.
Acta Pharmacol Sin ; 29(6): 687-97, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18501115

ABSTRACT

AIM: The aim of this study was to investigate whether superoxide dismutase (SOD) enzymes and ascorbate play a role in the protection of the nitrergic relaxation against superoxide anion inhibition in the mouse duodenum. METHODS: The effects of exogenous SOD, N,No-bis(salicylidene) ethylenediamine chloride (EUK-8; a synthetic cell-permeable mimetic of the manganese SOD [Mn-SOD] and ascorbate on relaxant responses induced by nitrergic nerve stimulation), exogenous nitric oxide (NO), and nitroglycerin were investigated in isolated mouse duodenum tissues. RESULTS: Diethyldithiocarbamate (DETCA) inhibited the relaxation to exogenous NO and nitroglycerin, but not relaxation to electrical field stimulation (EFS). SOD and ascorbate partially prevented the inhibitory effect of DETCA on relaxation to NO, abut not to nitroglycerin. The DETCA-induced inhibition on nitroglycerin was prevented by EUK-8. Hemoglobin, 2- (4-carboxyphenyl)-4,4,5,5-tetramethylimidazolinel-oxyl-3-oxide, and hydroxocobalamin inhibited the relaxation to NO, but not to EFS and nitroglycerin in the presence of DETCA. Pyrogallol and hydroquinone inhibited the relaxation to NO, but not to EFS and nitroglycerin. This inhibition was prevented by exogenous SOD and ascorbate, but was not prevented by EUK-8. Pyrogallol and hydroquinone did not inhibit the EFS-induced relaxation in the presence of DETCA. Duroquinone and 6-anilino-5.8-quinolinedione inhibited the relaxation to EFS, NO, and nitroglycerin, and this inhibition was prevented by EUK-8. CONCLUSION: These results suggest that the nitrergic neurotransmission in the mouse duodenum is protected by endogenous tissue antioxidants against superoxide anions, and Mn SOD, in addition to copper/zinc SOD, can protect NO from attack from superoxide anion generators intracellularly. Also, the possibility that the endogenous neurotransmitter may not be the free NO but a NO-containing or NO-generating molecule in the mouse duodenum remains open.


Subject(s)
Ascorbic Acid/pharmacology , Duodenum/physiology , Free Radical Scavengers/pharmacology , Muscle, Smooth/physiology , Nitric Oxide/physiology , Oxidants/metabolism , Superoxide Dismutase/physiology , Superoxides/metabolism , Animals , Antioxidants/pharmacology , Duodenum/drug effects , Estradiol/analogs & derivatives , Estradiol/pharmacology , Ethylenediamines/pharmacology , Female , In Vitro Techniques , Male , Mice , Muscle Relaxation/drug effects , Muscle Relaxation/physiology , Muscle, Smooth/drug effects , Organometallic Compounds/pharmacology
4.
Tohoku J Exp Med ; 213(1): 89-98, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17785957

ABSTRACT

Urocortin, a member of corticotropin releasing factor (CRF) peptide family, has positive chronotropic and inotropic effects on heart and also shows a vasodilatory effect. However, the mechanism underlying its vasodilatory effect has yet to be elucidated. Endothelium-dependent relaxation of resistance arteries is mainly achieved by activation of K+ channels. Therefore, we investigated possible role of K+ channels and hyperpolarization for the vasodilatory effect of urocortin using the isolated perfused rat mesenteric arteries. Urocortin (0.2 nM) produced a slow-onset decrease in the perfusion pressure of the mesenteric vascular bed, which was elevated by an alpha1-adrenoceptor agonist, phenylephrine (2-4 microM). Urocortin also hyperpolarized the main mesenteric artery. Removal of endothelium with saponin treatment considerably inhibited the relaxation and hyperpolarization induced by urocortin. In contrast, the hyperpolarization was not significantly changed by cyclooxygenase inhibitor, indomethacin (1 microM) and/or nitric oxide synthase inhibitor, N(omega)-nitro-L-arginine (100 microM). Urocortin-induced relaxation was not affected by the combination of a guanylyl cyclase inhibitor, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 1 microM), indomethacin and N(omega)-nitro-L-arginine. However, the relaxation and hyperpolarization were abolished by high extracellular potassium concentration (40 mM) or by a large conductance Ca(2+)-activated K+ channel blocker, charybdotoxin (1 nM). Glibenclamide (1 microM), an ATP-dependent K+ channel inhibitor, did not affect the relaxation and hyperpolarization. These results suggest that urocortin causes endothelium-dependent relaxation and hyperpolarization of rat mesenteric arteries, probably through the activation of charybdotoxin sensitive Ca2+-activated K+ channels. These findings also indicate an essential role of the endothelium for the urocortin-elicited vascular relaxation and hyperpolarization.


Subject(s)
Corticotropin-Releasing Hormone/pharmacology , Endothelium, Vascular/physiology , Mesenteric Artery, Superior/physiology , Potassium Channels, Calcium-Activated/physiology , Vasodilation/drug effects , Acetylcholine/pharmacology , Animals , Electrophysiology , Endothelium, Vascular/drug effects , Male , Mesenteric Artery, Superior/drug effects , Potassium Channels, Calcium-Activated/drug effects , Rats , Rats, Wistar , Urocortins
5.
Pharmacology ; 71(3): 128-34, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15161994

ABSTRACT

We investigated whether bacterial lipopolysaccharide treatment causes any neuronal and vascular hyporeactivity in mouse cavernous tissue and also whether melatonin has any restorative effect on this possible neuronal and vascular hyporesponsiveness. Lipopolysaccharide treatment attenuated contractions in response to phenylephrine. Treatment with the inducible nitric oxide synthase inhibitor aminoguanidine or melatonin restored the hypocontractility of the cavernous smooth muscle to phenylephrine. Relaxant responses of corpus cavernosum precontracted by phenylephrine to acetylcholine or electrical field stimulation were significantly impaired in mice treated with bacterial lipopolysaccharide. Treatment with aminoguanidine or melatonin could prevent the impairment of the neuronal and endothelial relaxations. There was no significant difference between control and lipopolysaccharide-treated groups in the contractile response to high-dose KCl and in the relaxant response to papaverine. In conclusion, bacterial lipopolysaccharide treatment caused a neuronal and endothelial dysfunction in the mouse corpus cavernosum. A possible increased oxidative activity in the cavernous tissue may be a major reason for the impairment of relaxant responses and hypocontracility of tissue. The restorative effects of melatonin on this hyporeactivity may depend on its antioxidant properties and partly on its inhibitory action on the inducible nitric oxide synthase production.


Subject(s)
Lipopolysaccharides/toxicity , Melatonin/pharmacology , Penis/drug effects , Acetylcholine/pharmacology , Animals , Electric Stimulation , Endothelium/drug effects , Endothelium/physiology , Escherichia coli , In Vitro Techniques , Male , Mice , Muscle Relaxation/drug effects , Muscle, Smooth/drug effects , Muscle, Smooth/physiology , Papaverine/pharmacology , Penis/blood supply , Penis/innervation , Vasodilator Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...